Zpride

Therapeutic Segment:
Anti-psychotic

Generic Name:
Levosulpride

Description:
LevosuIpiride is a substituted benzamide antipsychotic and prokinetic agent which is reported to be a selective antagonist of central and peripheral dopamine (D2, D3 and D4) receptors. Chemically it is N-[[(2S)-1- Ethylpyrrolidin- 2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide. Its molecular formula is C15H23N3O4S.

Indication:

Zpride (Levosulpiride) tablets are indicated for oral administration. Zpride (Levosulpiride) 25mg tablets are indicated for treatment of the following: -Gastroesophageal reflux disease. – Irritable bowel syndrome. – Dyspeptic syndrome due to delayed gastric emptying linked to organic factor (diabetic gastroparalysis, neoplasias, etc.) and/or to functional disorder. – Essential cephalgia. – Vertigo of a central and/or peripheral origin. Zpride (Levosulpiride) 50mg tablets are indicated for treatment of the following: – Endogenous and reactive depressive states. – Stomatic disorder. – Acute and chronic schizophrenia especially recommended for negative symptoms (after disorder).

Formulation:

  • Tablets

Strength:

  • 25mg
  • 50mg

Pack Size:

  • 2 x 10’s
Zpride-pack-copy-2